Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse MKT  >  AgeX Therapeutics Inc    AGE

AGEX THERAPEUTICS INC

(AGE)
SummaryQuotesChartsNewsCompany 
News SummaryMost relevantAll newsOfficial PublicationsSector news

AGEX THERAPEUTICS, INC. : Results of Operations and Financial Condition (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/14/2019 | 05:32pm EDT

Item 2.02 - Results of Operations and Financial Condition

On August 14, 2019, AgeX issued a press release announcing its financial results for the three and six months ended June 30, 2019. A copy of the press release is attached as Exhibit 99.1, which, in its entirety, is incorporated herein by reference.

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AGEX THERAPEUTICS INC
08/14AGEX THERAPEUTICS, INC. : Results of Operations and Financial Condition (form 8-..
AQ
08/14AGEX THERAPEUTICS : Management's Discussion and Analysis of Financial Condition ..
AQ
08/14AGEX THERAPEUTICS, INC. : Reports Second Quarter 2019 Financial Results and Prov..
BU
08/05AGEX THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
08/05AGEX THERAPEUTICS : Regenerative Medicine Leader Michael H. May Joins AgeX Board..
BU
07/09AGEX THERAPEUTICS' CEO DR. MICHAEL D : Investment Prospects & Advances in Resear..
BU
05/15AGEX THERAPEUTICS : Management's Discussion and Analysis of Financial Condition ..
AQ
05/15AGEX THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financi..
AQ
05/15AGEX THERAPEUTICS : Reports First Quarter 2019 Financial Results and Provides Bu..
BU
05/01AGEX THERAPEUTICS : to Participate at Biotech Investing in Longevity from Aikora..
BU
More news
Chart AGEX THERAPEUTICS INC
Duration : Period :
AgeX Therapeutics Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Managers
NameTitle
Michael D. West Chief Executive Officer & Director
Gregory H. Bailey Chairman
Michael H. Mulroy Director
John Francis Mauldin Director
Sector and Competitors
1st jan.Capitalization (M$)
AGEX THERAPEUTICS INC-3.68%103
IQVIA HOLDINGS INC34.91%30 701
LONZA GROUP36.75%26 363
INCYTE CORPORATION32.91%18 177
CELLTRION, INC.--.--%16 143
EXACT SCIENCES CORPORATION89.89%15 300